Show
Sort by
-
Development of ECM mimicking 3D-hydrogel scaffolds for liver tissue engineering
-
- Journal Article
- A1
- open access
Effect of proton pump inhibitors in infants with esophageal atresia on the gut microbiome : a pilot cohort
-
Gastric non-Helicobacter pylori Helicobacter species (NHPH) and disease : from animals to clinical relevance in humans
-
- Journal Article
- A1
- open access
Children with autoimmune liver disease have limited access to age : appropriate drug formulations, results from a European survey
-
Long-term obeticholic acid (OCA) for primary biliary cholangitis (PBC) in a clinical trial improved event free survival (death, liver transplant and hepatic decompensation) compared to external controls from the GLOBAL PBC real-world database
-
A multicentric study to estimate mortality and graft loss risk after liver transplantation (LT) in patients with recurrent primary biliary cholangitis (PBC)
-
Enhanced liver fibrosis score correlates with transient elastography in patients with treated autoimmune hepatitis
-
Adipose tissue insulin resistance is a determinant of disease severity in pediatric nonalcoholic fatty liver disease
-
Long-term obeticholic acid for primary biliary cholangitis in a clinical trial improved event-free survival (death, liver transplantation, and hepatic decompensation) compared with external controls from the GLOBAL PBC real-world database
(2022) JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. In Journal of Gastroenterology and Hepatology 37(Supplement 1). p.59-59 -
Long-term obeticholic acid (OCA) for primary biliary cholangitis (PBC) in a clinical trial improved event free survival (death, liver transplant and hepatic decompensation) compared to external controls from the global PBC real-world database